Evidence map›Paper›PMID 24921985›Full record

ArticleNPJ primary care respiratory medicine2014

Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey.

David Price, Monica Fletcher, Thys van der Molen

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in NPJ primary care respiratory medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05593315 (Efficacy of the Combination of General Relaxation), which is not on this map. Cited by 249 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
249citing papers in PubMed, 6 pooled it
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05593315 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Efficacy of the Combination of General Relaxation (Mindfulness) and Respiratory (Buteyko) Techniques for the Improvement of Poorly Controlled Asthma. The MBA Study

TypeinterventionalSponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2023 to 2025Enrolled40ConditionsAsthma, Anxiety, StressArmsMindfulness and Buteyko techniques
3 · Its place in the literature

Who cites it

249 citing papers in PubMed, 6 syntheses or guidelines pooled it, 558 citations in OpenAlex.

  1. Anti-IL-5 therapies for asthma.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Anti-IL5 therapies for asthma.The Cochrane database of systematic reviews · 2017
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Cost-consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma.The European journal of health economics : HEPAC : health economics in prevention and care · 2020
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. Fevipiprant, an oral prostaglandin DPThe European respiratory journal · 2017
    Trial
  17. Article
  18. Article
  19. Article
  20. Article

189 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

David PriceCentre of Academic Primary Care, University of Aberdeen, Aberdeen, UK.
Monica FletcherEducation for Health, Warwick, UK.
Thys van der MolenDepartment of General Practice, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Health Education England · GBUniversity of Aberdeen · GBUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma is one of the most common chronic diseases in the world, and previous studies have reported low levels of control. Recent developments in the availability and use of online sources of information about asthma might add to patients' knowledge and help improve control.

aimsTo investigate whether asthma control has improved by assessing levels of symptoms, exacerbations and Global Initiative for Asthma-defined control in a real-life population of patients who use the Internet and social media, as well as evaluate patient perception of control and attitudes to asthma.

methodsOnline surveys were conducted among 8,000 patients with asthma (aged 18-50 years, ≥2 prescriptions in the previous 2 years, use of social media) from 11 European countries.

resultsLevels of asthma control were low: 45% of respondents had uncontrolled asthma. Acute exacerbations were common: 44% of respondents reported having used oral steroids for asthma in the previous 12 months, 24% had visited an emergency department and 12% had been hospitalised. More than 80% of respondents (overall, and among those with a history of exacerbations) considered their asthma to be controlled. Of those who had an exacerbation requiring oral steroids, 75% regarded their asthma as not serious.

conclusionsAsthma control in Europe remains poor; symptoms and exacerbations are common. Many patients regard their asthma as controlled and not serious despite experiencing symptoms and exacerbations. There is a need to assess patients' control, risk and inhaler technique, and to ensure that patients are prescribed, and take, appropriate treatments.

Indexed as

AdolescentAdultAnti-Asthmatic AgentsAsthmaAttitude to HealthEuropeFemaleHealth SurveysHumansMaleMiddle AgedSurveys and QuestionnairesTreatment OutcomeYoung AdultAnti-Asthmatic Agents

Identifiers

PMID24921985
PMCPMC4373302
OpenAlexW2161775889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.